vs
Protagonist Therapeutics, Inc（PTGX）与RESOURCES CONNECTION, INC.（RGP）财务数据对比。点击上方公司名可切换其他公司
Protagonist Therapeutics, Inc的季度营收约是RESOURCES CONNECTION, INC.的1.4倍（$170.6M vs $117.7M），Protagonist Therapeutics, Inc净利率更高（77.2% vs -10.8%，领先87.9%），Protagonist Therapeutics, Inc同比增速更快（184.4% vs -19.2%），Protagonist Therapeutics, Inc自由现金流更多（$182.8M vs $15.6M）
Protagonist Therapeutics是一家临床阶段生物制药公司，专注于研发创新肽类靶向疗法，以满足胃肠道疾病、炎症性疾病及罕见病领域未被满足的医疗需求，核心候选产品覆盖炎症性肠病等慢性免疫相关适应症。
RGP原名 Resources Global Professionals，是 Resources Connection, Inc. 的核心运营主体，面向全球客户提供多领域专业咨询服务，覆盖财务会计、信息管理、治理风险合规、人力资本、法务监管、企业咨询与重组、战略传播以及供应链管理等板块。
PTGX vs RGP — 直观对比
营收规模更大
PTGX
是对方的1.4倍
$117.7M
营收增速更快
PTGX
高出203.5%
-19.2%
净利率更高
PTGX
高出87.9%
-10.8%
自由现金流更多
PTGX
多$167.2M
$15.6M
损益表 — Q4 FY2024 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $170.6M | $117.7M |
| 净利润 | $131.7M | $-12.7M |
| 毛利率 | — | 37.1% |
| 营业利润率 | 74.3% | -10.3% |
| 净利率 | 77.2% | -10.8% |
| 营收同比 | 184.4% | -19.2% |
| 净利润同比 | 381.7% | 81.6% |
| 每股收益（稀释后） | $2.01 | $-0.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PTGXRGP
| Q4 25 | — | $117.7M | ||
| Q3 25 | — | $120.2M | ||
| Q2 25 | — | $139.3M | ||
| Q1 25 | — | $129.4M | ||
| Q4 24 | $170.6M | $145.6M | ||
| Q3 24 | — | $136.9M | ||
| Q2 24 | — | $148.2M | ||
| Q1 24 | $255.0M | $151.3M |
净利润PTGXRGP
| Q4 25 | — | $-12.7M | ||
| Q3 25 | — | $-2.4M | ||
| Q2 25 | — | $-73.3M | ||
| Q1 25 | — | $-44.1M | ||
| Q4 24 | $131.7M | $-68.7M | ||
| Q3 24 | — | $-5.7M | ||
| Q2 24 | — | $10.5M | ||
| Q1 24 | $207.3M | $2.5M |
毛利率PTGXRGP
| Q4 25 | — | 37.1% | ||
| Q3 25 | — | 39.5% | ||
| Q2 25 | — | 40.2% | ||
| Q1 25 | — | 35.1% | ||
| Q4 24 | — | 38.5% | ||
| Q3 24 | — | 36.5% | ||
| Q2 24 | — | 40.2% | ||
| Q1 24 | — | 37.0% |
营业利润率PTGXRGP
| Q4 25 | — | -10.3% | ||
| Q3 25 | — | -1.7% | ||
| Q2 25 | — | -47.0% | ||
| Q1 25 | — | -38.4% | ||
| Q4 24 | 74.3% | -52.7% | ||
| Q3 24 | — | -3.5% | ||
| Q2 24 | — | 7.6% | ||
| Q1 24 | 80.9% | 2.8% |
净利率PTGXRGP
| Q4 25 | — | -10.8% | ||
| Q3 25 | — | -2.0% | ||
| Q2 25 | — | -52.6% | ||
| Q1 25 | — | -34.0% | ||
| Q4 24 | 77.2% | -47.2% | ||
| Q3 24 | — | -4.2% | ||
| Q2 24 | — | 7.1% | ||
| Q1 24 | 81.3% | 1.7% |
每股收益（稀释后）PTGXRGP
| Q4 25 | — | $-0.38 | ||
| Q3 25 | — | $-0.07 | ||
| Q2 25 | — | $-2.21 | ||
| Q1 25 | — | $-1.34 | ||
| Q4 24 | $2.01 | $-2.08 | ||
| Q3 24 | — | $-0.17 | ||
| Q2 24 | — | $0.31 | ||
| Q1 24 | $3.26 | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $418.9M | $89.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $675.3M | $194.6M |
| 总资产 | $744.7M | $289.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PTGXRGP
| Q4 25 | — | $89.8M | ||
| Q3 25 | — | $77.5M | ||
| Q2 25 | — | $86.1M | ||
| Q1 25 | — | $72.5M | ||
| Q4 24 | $418.9M | $78.2M | ||
| Q3 24 | — | $89.6M | ||
| Q2 24 | — | $108.9M | ||
| Q1 24 | $322.6M | $113.8M |
股东权益PTGXRGP
| Q4 25 | — | $194.6M | ||
| Q3 25 | — | $206.4M | ||
| Q2 25 | — | $207.1M | ||
| Q1 25 | — | $277.8M | ||
| Q4 24 | $675.3M | $325.7M | ||
| Q3 24 | — | $407.2M | ||
| Q2 24 | — | $418.8M | ||
| Q1 24 | $560.4M | $414.9M |
总资产PTGXRGP
| Q4 25 | — | $289.3M | ||
| Q3 25 | — | $287.2M | ||
| Q2 25 | — | $304.7M | ||
| Q1 25 | — | $375.6M | ||
| Q4 24 | $744.7M | $424.9M | ||
| Q3 24 | — | $512.9M | ||
| Q2 24 | — | $510.9M | ||
| Q1 24 | $629.3M | $523.2M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $184.2M | $15.9M |
| 自由现金流经营现金流 - 资本支出 | $182.8M | $15.6M |
| 自由现金流率自由现金流/营收 | 107.1% | 13.2% |
| 资本支出强度资本支出/营收 | 0.8% | 0.3% |
| 现金转化率经营现金流/净利润 | 1.40× | — |
| 过去12个月自由现金流最近4个季度 | $101.7M | $24.3M |
8季度趋势，按日历期对齐
经营现金流PTGXRGP
| Q4 25 | — | $15.9M | ||
| Q3 25 | — | $-7.8M | ||
| Q2 25 | — | $16.8M | ||
| Q1 25 | — | $659.0K | ||
| Q4 24 | $184.2M | $1.8M | ||
| Q3 24 | — | $-309.0K | ||
| Q2 24 | — | $3.2M | ||
| Q1 24 | $-27.4M | $20.5M |
自由现金流PTGXRGP
| Q4 25 | — | $15.6M | ||
| Q3 25 | — | $-8.0M | ||
| Q2 25 | — | $16.5M | ||
| Q1 25 | — | $238.0K | ||
| Q4 24 | $182.8M | $61.0K | ||
| Q3 24 | — | $-575.0K | ||
| Q2 24 | — | $3.0M | ||
| Q1 24 | $-27.7M | $20.4M |
自由现金流率PTGXRGP
| Q4 25 | — | 13.2% | ||
| Q3 25 | — | -6.6% | ||
| Q2 25 | — | 11.8% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | 107.1% | 0.0% | ||
| Q3 24 | — | -0.4% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | -10.9% | 13.5% |
资本支出强度PTGXRGP
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | 0.8% | 1.2% | ||
| Q3 24 | — | 0.2% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | 0.1% | 0.1% |
现金转化率PTGXRGP
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.40× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.30× | ||
| Q1 24 | -0.13× | 8.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PTGX
暂无分部数据
RGP
| US | $93.7M | 80% |
| Non Us | $24.0M | 20% |
